Top

Supportive Care in Cancer

Published in:

01-11-2009 | Original Article

Prevalence of depression among cancer patients in Jordan: a national survey

Authors: N. M. Mhaidat, K. H. Alzoubi, S. Al-Sweedan, B. A. Alhusein

Published in: Supportive Care in Cancer | Issue 11/2009

Abstract

Goals

The aim of this study is to investigate the prevalence of depression among cancer patients in Jordan and to study the relation between several socio-demographic, disease- and treatment-related factors, and the occurrence of depression among those cancer patients.

Patients and methods

A cross-sectional survey study was conducted at a major university hospital in Jordan. Cancer patients were interviewed for socio-demographic information and medical records were checked for information about disease and treatment of patient. Patients’ psychological status was assessed using The Hospital Anxiety and Depression Scale (HADS).

Results

The prevalence of depression in our sample was 51.9%. Significant correlation was detected between depression and appetite among cancer patients. Knowledge of having cancer and stage of the disease were also significantly associated with occurrence of depression.

Conclusion

In an effort to reduce the occurrence of depression among cancer patients, special attention is needed for changes in the psychological status in patients with knowledge about their diagnosis and patients in advanced disease stage.

De Boer MF, Ryckman RM, Pruyn JF, Van den Borne HW (1999) Psychosocial correlates of cancer relapse and survival: a literature review. Patient Educ Couns 37:215–230 doi:10.1016/S0738-3991(99)00029-4 CrossRefPubMed

Smith ML, Newland AC (1999) Treatment of myeloma. QJM 92:11–14 doi:10.1093/qjmed/92.1.11 CrossRefPubMed

Pirl WF (2004) Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. J Natl Cancer Inst Monogr 32:32–39 doi:10.1093/jncimonographs/lgh026 CrossRefPubMed

McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB (1995) Depression in patients with cancer: diagnosis, biology, and treatment. Arch Gen Psychiatry 52:89–99PubMed

Chochinov HM (2001) Depression in cancer patients. Lancet Oncol 2:499–505 doi:10.1016/S1470–2045(01)00456–9 CrossRefPubMed

Derogatis LR, Morrow GR, Fetting J et al (1983) The prevalence of psychiatric disorders among cancer patients. JAMA 249:751–757 doi:10.1001/jama.249.6.751 CrossRefPubMed

Le Fevre P, Devereux J, Smith S (1999) Screening for psychiatric illness in the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12. Palliat Med 13:399–407 doi:10.1191/026921699671260095 CrossRefPubMed

Sharpe M, Strong V, Allen K et al (2004) Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs. Br J Cancer 90:314–320 doi:10.1038/sj.bjc.6601578 CrossRefPubMed

Trask PC (2004) Assessment of depression in cancer patients. J Natl Cancer Inst Monogr 32:80–92 doi:10.1093/jncimonographs/lgh013 CrossRefPubMed

10.

Berard RMF, Boermeester F, Viljoen G (1998) Depressive disorders in an out-patient oncology setting: prevalence, assessment, and management. Psychooncology 7:112–120 doi:10.1002/(SICI)1099-1611(199803/04)7:2<112::AID-PON300>3.0.CO;2-W CrossRefPubMed

11.

Block SD (2000) Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians-American Society of Internal Medicine. Ann Intern Med 132:209–218PubMed

12.

Carlsen K, Jensen AB, Jacobsen E, Krasnik M, Johansen C (2005) Psychosocial aspects of lung cancer. Lung Cancer 47:293–300 doi:10.1016/j.lungcan.2004.08.002 CrossRefPubMed

13.

Hopwood P, Stephens RJ (2000) Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 18:893–908PubMed

14.

Hotopf M, Chidgey J, Addington-Hall J, Ly KL (2002) Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med 16:81–97 doi:10.1191/02169216302pm507oa CrossRefPubMed

15.

Wong-Kim EC, Bloom JR (2005) Depression experienced by young women newly diagnosed with breast cancer. Psychooncology 7:564–573 doi:10.1002/pon.873

16.

Massie MJ, Gagnon P, Holland JC (1994) Depression and suicide in patients with cancer. J Pain Symptom Manage 7:99–109 doi:10.1016/0885-3924(92)90121-W CrossRef

17.

Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370 doi:10.1111/j.1600-0447.1983.tb09716.x CrossRefPubMed

18.

19.

Carroll BT, Kathol RG, Noyes R Jr et al (1993) Screening for depression and anxiety in cancer patients using the Hospital Anxiety and Depression Scale. Gen Hosp Psychiatry 15:69–74 doi:10.1016/0163-8343(93)90099-A CrossRefPubMed

20.

Chochinov HM (2001) Depression in cancer patients. Lancet Oncol 2:499–505 doi:10.1016/S1470-2045(01)00456-9 CrossRefPubMed

21.

Jacobsen PB, Jim HS (2008) Achievements and challenges psychosocial interventions for anxiety and depression in adult cancer patients: achievements and challenges. CA Cancer J Clin 58:214–230 doi:10.3322/CA.2008.0003 CrossRefPubMed

22.

Fallowfield L, Ratcliffe D, Jenkins V, Saul J (2001) Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 84:1011–1015 doi:10.1054/bjoc.2001.1724 CrossRefPubMed

23.

Tavoli A, Mohagheghi MA, Montazeri A, Roshan R, Tavoli Z, Omidvari S (2007) Anxiety and depression in patients with gastrointestinal cancer: does knowledge of cancer diagnosis matter? BMC Gastroenterol 7:28 doi:10.1186/1471-230X-7-28 CrossRefPubMed

24.

Ashbury FD, Madlensky L, Raich P, Thompson M, Whitney G, Hotz K, Kralj B, Edell WS (2003) Antidepressant prescribing in community cancer care. Support Care Cancer 11:278–285PubMed

25.

Passik SD, Dugan W, McDonald MV, Rosenfeld B, Theobald DE, Edgerton S (1998) Oncologists’ recognition of depression in their patients with cancer. J Clin Oncol 16:1594–1600PubMed

26.

Passik SD, Breitbart WS (1996) Depression in patients with pancreatic carcinoma; diagnostic and treatment issues. Cancer 78:615–626PubMed

27.

Arai Y, Kawakita M, Hida S, Terachi T, Okada Y, Yoshida O (1996) Psychosocial aspects of longterm survivors of testicular cancer. J Urol 155:574–578 doi:10.1016/S0022-5347(01)66452-8 CrossRefPubMed

28.

Jacobsen P, Bovbjerg D, Redd W (1993) Anticipatory anxiety in women receiving chemotherapy for breast cancer. Health Psychol 12:469–475 doi:10.1037/0278-6133.12.6.469 CrossRefPubMed

29.

van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, Rodenhuis S (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210–218 doi:10.1093/jnci/90.3.210 CrossRefPubMed

30.

Patten SB, Neutel I (2000) Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf 22:111–122 doi:10.2165/00002018-200022020-00004 CrossRefPubMed

Title: Prevalence of depression among cancer patients in Jordan: a national survey
Authors: N. M. Mhaidat
K. H. Alzoubi
S. Al-Sweedan
B. A. Alhusein
Publication date: 01-11-2009
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 11/2009
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-009-0600-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Goals

Patients and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2009

A descriptive review of the factors contributing to nutritional compromise in patients with head and neck cancer

Comparison between numerical rating scale and six-level verbal rating scale in cancer patients with pain: a preliminary report

Determinants and implications of cancer patients’ psychosocial needs

Intrusion and avoidance in subjects undergoing genetic investigation and counseling for hereditary cancer

Saliva substitutes for the treatment of radiation-induced xerostomia—a review

Longitudinal oncology registry of head and neck carcinoma (LORHAN®): initial supportive care findings

Keynote webinar | Spotlight on antibody–drug conjugates in cancer